Skip to main content

Table 2 Fatty acid profiles in plasma of controls, and CAD patients determined by gas chromatography

From: Correlation of trans fatty acids with the severity of coronary artery disease lesions

  Controls
n = 120
CAD patients
n = 111
Trans Fatty acids
 C16:1 trans 11 0.59 ± 0.17 0.67 ± 0.25*
 C18:1 trans 9 0.15 ± 0.14 0.34 ± 0.23**
 C18:1 trans 11 0.36 ± 0.20 0.72 ± 0.56**
 C18:2 trans 9 trans 12 0.26 ± 0.47 0.41 ± 0.26**
 C18:2 trans 9 cis 12 0.19 ± 0.14 0.30 ± 0.18**
 C18:2 cis 9 trans 12 0.21 ± 0.12 0.37 ± 0.23**
 C20:1 trans 11 0.23 ± 0.31 0.41 ± 0.40**
 C18:2 cis 9 trans 11 0.33 ± 0.32 0.42 ± 0.37*
 C18:2 trans 10 cis 12 0.34 ± 0.34 0.53 ± 0.38**
Cis Fatty acids
 C16:1 cis 11 1.33 ± 0.31 2.67 ± 0.88**
 C18:1 cis 9 13.18 ± 3.71 15.95 ± 3.28**
 C18:1 cis 11 2.21 ± 0.73 2.08 ± 0.57
 C18:2 cis 9 cis 12 31.88 ± 6.44 20.56 ± 3.37**
 C20:1 cis 11 0.80 ± 0.46 0.70 ± 0.37*
 Σ Trans FA 2.68 ± 1.07 4.19 ± 1.96**
 Σ Cis FA 49.41 ± 5.86 41.97 ± 5.14**
 Σ SFA 34.01 ± 5.27 37.14 ± 3.41**
 Σ MUFA 20.25 ± 3.48 24.55 ± 3.28**
 Σ PUFA 43.05 ± 5.90 34.12 ± 2.93**
 Σ UFA 63.30 ± 5.24 58.67 ± 3.60**
  1. Data are expressed as relative values (%): mean % of total FA ± SD from two independent experiments conducted in triplicate for each patients and controls
  2. Σ Trans FA sum of trans fatty acids, Σ cis FA sum of cis fatty acids, Σ SFA sum of saturated fatty acids, Σ UFA sum of unsaturated fatty acids, Σ PUFA sum of polyunsaturated fatty acids, Σ MUFA sum of monounsaturated fatty acids
  3. A significant difference between controls and patients is indicated by *(p < 0.05) and **: p < 0.001. The Mann-Whitney test was used